Although cell death was observed in both PC3Control cells and PC3AGR−2sh cells, PC3AGR−2sh cells survived the TRAIL challenge significantly better than the PC3Control cells (Figure 6A) suggesting loss of AGR-2 might be associated with development of anoikis resistance in malignant tumor cells. This evidence concerns the gene AGR2 and cancer.